GlaxoSmithKline PLCGSK:LSE

27.50 / 1.79%
5.62 %
Close in GBXToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Apr 27 2015 17:09 BST.

Consensus recommendation

As of Apr 24, 2015, the consensus forecast amongst 29 polled investment analysts covering GlaxoSmithKline plc advises investors to hold their position in the company. This has been the consensus forecast since the sentiment of investment analysts deteriorated on Feb 21, 2013. The previous consensus forecast advised that GlaxoSmithKline plc would outperform the market.

Previous recommendations
Last year3 months ago2 months ago4 weeks agoLatest
Mouseover chart recommendation details.
Latest recommendation
No opinion0

Share price forecast

The 23 analysts offering 12 month price targets for GlaxoSmithKline plc have a median target of 1,541, with a high estimate of 1,840 and a low estimate of 1,330. The median estimate represents a -1.34 % decrease from the last price of 1,562. View Full Financials

High+17.8 %1,840
Med-1.3 %1,541
Low-14.9 %1,330


In 2014, GlaxoSmithKline PLC reported a dividend of 0.80 GBP, which represents a 2.56% increase over last year. The 20 analysts covering the company expect dividends of 0.81 GBP for the upcoming fiscal year, an increase of 0.88%. View Full Financials

Div growth (TTM)+2.56 %
  • Mouseover chart for details.
  • Dividend forecast
  • Quarter 1
  • Quarter 2
  • Quarter 3
  • Quarter 4

Earnings history & estimates

On Feb 04, 2015, GlaxoSmithKline plc reported 4th quarter 2014 earnings of 0.215 per share. This result under-performed the 0.26 consensus expectations of the 9 analysts following the company but under-performed last year's 4th quarter results by 28.57 %.
The next earnings announcement is expected on May 06, 2015. View Full Interim Financials

Average growth rate-3.89 %

GlaxoSmithKline plc reported annual 2014 earnings of 0.954 per share on Feb 04, 2015.
The next earnings announcement from GlaxoSmithKline plc is expected the week of Feb 08, 2016. View Full Annual Financials

Average growth rate-7.49 %
  • Mouseover chart for details.
  • Reported results
  • Forecasts
  • Pos/Neg restatement


GlaxoSmithKline plc had 4th quarter 2014 revenues of 6bn. This missed the 6bn consensus estimate of the 9 analysts following the company. This was 9.56% above the prior year's 4th quarter results. View Full Interim Financials

Average growth rate-2.14 %

GlaxoSmithKline plc had revenues for the full year 2014 of 23bn. This was 13.20 % below the prior year's results. View Full Annual Financials

Average growth rate-4.99 %
  • Mouseover chart for details.
  • Reported results
  • Forecasts
  • Pos/Neg restatement
© Thomson Reuters Click for restrictions.

All markets data located on is subject to the FT Terms & Conditions.

All content on is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.